EDIT vs MTD
Editas Medicine Inc (EDIT) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
EDIT currently screens at market cap $375.2M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the EDIT and MTD stock pages for the full models.
Not investment advice.